DNA plasmid production in different host strains of Escherichia coli

Journal of Industrial Microbiology and Biotechnology

Volumn 36, Issue 4, 2009, Pages 521-530

  Singer, Adam ^a   Eiteman, Mark A ^b   Altman, Elliot ^b  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b University of Georgia   (United States)

Author keywords

DNA yield; Fed batch process; Heat treatment; Supercoiled DNA

Indexed keywords

BIOREACTORS; CULTURE MEDIA; DNA, BACTERIAL; ESCHERICHIA COLI; PLASMIDS;

ESCHERICHIA COLI;

EID: 63049124317     PISSN: 13675435     EISSN: 14765535     Source Type: Journal    
DOI: 10.1007/s10295-008-0522-7     Document Type: Article

References (52)

1. CN Arnold J McElhanon A Lee R Leonhart DA Siegele 2001 Global analysis of Escherichia coli gene expression during the acetate-induced acid tolerance response J Bacteriol 183 7 2178 2186 10.1128/JB.183.7.2178-2186.2001
2. WE Bentley N Mirjalili DC Andersen RH Davis DS Kompala 1990 Plasmid-encoded protein: the principal factor in the metabolic burden associated with recombinant bacteria Biotechnol Bioeng 35 668 681 10.1002/bit.260350704
3. JA Berzofsky T Masaki O SangKon IM Belyakov JD Ahlers JE Janik JC Morris 2004 Progress on new vaccine strategies for the immunotherapy and prevention of cancer J Clin Invest 113 1515 1525
4. AE Carnes 2005 Fermentation design for the manufacture of therapeutic plasmid DNA BioProcess Intl 3 36 44
5. AE Carnes CP Hodgson JA Williams 2006 Inducible Escherichia coli fermentation for increased plasmid DNA production Biotechnol Appl Biochem 45 155 166 10.1042/BA20050223
6. AT Catanzaro M Roederer RA Koup RT Bailer ME Enama MC Nason JE Martin S Rucker CA Andrews PL Gomez JR Mascola GJ Nabel BS Graham 2007 Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine Vaccine 25 4085 4092 10.1016/j.vaccine.2007.02.050
7. W Chen C Graham RB Ciccarelli 1997 Automated fed-batch fermentation with feed-back controls based on dissolved oxygen (DO) and pH for production of DNA vaccines J Ind Microbiol Biotechnol 18 43 48 10.1038/sj.jim.2900355
8. J Donnelly K Berry J Ulmer 2003 Technical and regulatory hurdles for DNA vaccines Int J Parasitol 33 457 467 10.1016/S0020-7519(03)00056-0
9. RH Durland EM Eastman 1998 Manufacturing and quality control of plasmid-based gene expression systems Adv Drug Deliv Rev 30 33 48 10.1016/S0169-409X(97)00105-1
10. MA Eiteman MJ Chastain 1997 Optimization of the ion-exchange analysis of organic acids from fermentation Anal Chim Acta 338 69 75 10.1016/S0003-2670(96) 00426-6
11. MA Eiteman E Altman 2006 Overcoming acetate in Escherichia coli recombinant protein fermentations Trends Biotechnol 24 530 536 10.1016/j.tibtech.2006.09.001
12. B Engberg K Nordström 1975 Replication of R-factor R1 in Escherichia coli K-12 at different growth rates J Bacteriol 123 1 179 186
13. T Fitzwater X Zhang R Elblel B Polisky 1988 Conditional high copy number ColE 1 mutants: resistance to RNA1 inhibition in vivo and in vitro EMBO J 7 3289 3297
14. SC Gilbert VS Moorthy L Andrews AA Pathan SJ McConkey JM Vuola SM Keating T Berthoud D Webster H McShane AV Hill 2006 Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis Vaccine 24 4554 4561 10.1016/j.vaccine.2005.08.048
15. V Glaser 1997 Promise of gene therapy for treating disease remains on trial in the clinic Genet Eng News 14 33 34
16. BR Glick 1995 Metabolic load and heterologous gene expression Biotechnol Adv 13 247 261 10.1016/0734-9750(95)00004-A
17. J Hartikka M Sawdey F Cornefert-Jensen M Margalith K Barnhart M Nolasco HL Vahlsing J Meek M Marquet P Hobart J Norman M Manthorpe 1996 An improved plasmid DNA expression vector for direct injection into skeletal muscle Hum Gene Ther 7 1205 1217 10.1089/hum.1996.7.10-1205
18. M Hecker A Schroeter F Mach 1985 Escherichia coli relA strains as hosts for amplification of pBR322 plasmid DNA FEMS Microbiol Lett 29 331 334 10.1111/j.1574-6968.1985.tb00885.x
19. JE Herrmann 2006 DNA vaccines against enteric infections Vaccine 24 3705 3708 10.1016/j.vaccine.2005.07.012
20. RC Jones RM Anthony 1977 The relationship between nutrient feed rate and specific growth rate in fed batch cultures Appl Microbiol Biotechnol 4 87 92
21. K Jones-Prather MC Edmonds JW Herod 2006 Identification and characterization of IS1 transposition in plasmid amplification mutants of E. coli clones producing DNA vaccines Appl Microbiol Biotechnol 73 815 826 10.1007/s00253-006-0532-1
22. K Jones-Prather KS Sager J Murphy M Chartrain 2003 Industrial scale production of plasmid DNA for vaccine and gene therapy: plasmid design, production, and purification Enzyme Microb Technol 33 865 883 10.1016/S0141-0229(03)00205-9
23. DJ Laddy J Yan N Corbitt D Kobasa GP Kobinger DB Weiner 2007 Immunogenicity of novel consensus-based DNA vaccines against avian influenza Vaccine 25 2984 2989 10.1016/j.vaccine.2007.01.063
24. R Lahijani G Hulley G Soriano NA Horn M Marquet 1996 High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutation Hum Gene Ther 7 1971 1980 10.1089/hum.1996.7.16-1971
25. S Lin-Chao H Bremer 1986 Effect of the bacterial growth rate on replication control of plasmid pBR322 in Escherichia coli Mol Gen Genet 203 143 149 10.1007/BF00330395
26. K Listner L Bentley J Okonkowski C Kistler R Wnek A Caparoni B Junker D Robinson P Salmon M Chartrain 2006 Development of a highly productive and scalable plasmid DNA production platform Biotechnol Prog 22 1335 1345 10.1021/bp060046h
27. DB Lowe MH Shearer CA Jumper RC Kennedy 2007 Towards progress on DNA vaccines for cancer Cell Mol Life Sci 64 2391 2403 10.1007/s00018-007-7165-0
28. T Miki T Yasukochi H Nagatani M Furuno T Orita H Yamada T Imoto T Horiuchi 1987 Construction of a plasmid vector for the regulatable high level expression of eukaryotic genes in Escherichia coli: an application to overproduction of chicken lysozyme Protein Eng 1 327 332 10.1093/protein/1.4.327
29. WW Nichols BJ Ledwith SV Manam PJ Troilo 1995 Potential DNA vaccine integration into host cell genome Ann N Y Acad Sci 27 30 39 10.1111/j.1749-6632. 1995.tb44729.x
30. J Okonkowski L Kizer-Bentley K Listner D Robinson M Chartrain 2005 Development of a robust, versatile, and scalable inoculum train for the production of a DNA vaccine Biotechnol Prog 21 1038 1047 10.1021/bp040041p
31. RD O'Kennedy C Baldwin E Keshavarz-Moore 2000 Effects of growth medium selection on plasmid DNA production and initial processing steps J Biotechnol 76 175 183 10.1016/S0168-1656(99)00187-X
32. RD O'Kennedy JM Ward E Keshavarz-Moore 2003 Effects of fermentation strategy on the characteristics of plasmid DNA production Biotechnol Appl Biochem 37 83 90 10.1042/BA20020099
33. DMF Prazeres GNM Ferreira GA Monteiro CL Cooney JMS Cabral 1999 Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: problems and bottlenecks Trends Biotechnol 17 169 174 10.1016/S0167-7799(98) 01291-8
34. P Reinikainen K Korpela V Nissinen J Olkku H Soderlund P Markkanen 1989 Escherichia coli plasmid production in a fermenter Biotechnol Bioeng 33 386 393 10.1002/bit.260330403
35. P Reinikainen I Virkajärvi 1989 Escherichia coli growth and plasmid copy numbers in continuous cultivations Biotechnol Lett 11 4 225 230 10.1007/BF01031568
36. A Rozkov CA Avignone-Rossa PF Ertl P Jones RD O'Kennedy JJ Smith JW Dale ME Bushell 2006 Fed batch culture with declining specific growth rate for high-yielding production of a plasmid containing a gene therapy sequence in Escherichia coli DH1 Enzyme Microb Technol 39 47 50 10.1016/j.enzmictec.2005.09. 005
37. Schmidt T, Friehs K, Flaschel E, Schleef M (2003) Method for the isolation of plasmid DNA. US Patent 6,664,078
38. J Seo JE Bailey 1985 Effects of recombinant plasmid content on growth properties and cloned gene product formation in Escherichia coli Biotechnol Bioeng 27 1668 1674 10.1002/bit.260271207
39. J Seo JE Bailey 1986 Continuous cultivation of recombinant Escherichia coli: existence of an optimum dilution rate for maximum plasmid and gene product concentration Biotechnol Bioeng 28 1590 1594 10.1002/bit.260281018
40. PA Shamlou 2003 Scaleable processes for the manufacture of therapeutic quantities of plasmid DNA Biotechnol Appl Biochem 37 207 218 10.1042/BA20030011
41. RL Sheets J Stein S Manetz D Duffy M Nason 2006 Biodistribution of DNA plasmid vaccines against HIV-1, ebola severe acute respiratory syndrome, or west Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts Toxicol Sci 91 610 619 10.1093/toxsci/kfj169
42. J Shiloach R Fass 2005 Growing E. coli to high cell density: a historical perspective on method development Biotechnol Adv 23 345 357 10.1016/j.biotechadv.2005.04.004
43. R Siegel DD Ryu 1985 Kinetic study of instability of recombinant plasmid pPLc23trpAI in E. coli using two-stage continuous culture system Biotechnol Bioeng 27 1 28 33 10.1002/bit.260270105
44. B Spira X Hu T Ferenci 2008 Strain variation in ppGpp concentration and RpoS levels in laboratory strains of Escherichia coli K-12 Microbiology 154 2887 2895 10.1099/mic.0.2008/018457-0
45. T Tamm B Polisky 1985 Characterization of the ColE1 primer-RNA1 complex: analysis of a domain of ColE1 RNA1 necessary for its interaction with primer RNA Proc Natl Acad Sci USA 82 2257 2261 10.1073/pnas.82.8.2257
46. R Tuteja 2002 DNA vaccine against malaria: a long way to go Crit Rev Biochem Mol Biol 37 29 54 10.1080/10409230290771447
47. US Dept of Health and Human Services, Food and Drug Administration (2007) Guidance for industry: considerations for plasmid DNA vaccines for infectious disease indications, November 2007
48. Z Wang Z Yuan UR Henggeb 2004 Processing of plasmid DNA with ColE1-like replication origin Plasmid 51 149 161 10.1016/j.plasmid.2003.12.002
49. H Weintraub PF Cheng K Conrad 1986 Expression of transfected DNA depends on DNA topology Cell 46 115 122 10.1016/0092-8674(86)90865-2
50. EM Wong MA Muesing B Polisky 1982 Temperature-sensitive copy number mutants of ColE1 are located in an untranslated region of the plasmid genome Proc Natl Acad Sci USA 79 3570 3574 10.1073/pnas.79.11.3570
51. Z Xu W Shen H Chen P Cen 2005 Effects of medium composition on the production of plasmid DNA vector potentially for human gene therapy J Zhejiang Univ Sci 6B 396 400 10.1631/jzus.2005.B0396
52. SY Yau E Keshavarz-Moore J Ward 2008 Host strain influences on supercoiled plasmid DNA production in Escherichia coli: implications for efficient design of large-scale processes Biotechnol Bioeng 101 529 544 10.1002/bit.21915